Mechanisms of converting enzyme inhibition: studies in experimental animals.
D015097:3-Mercaptopropionic Acid / Q000031:analogs & derivatives / Q000494:pharmacology; D000806:Angiotensin-Converting Enzyme Inhibitors; D000818:Animals; D000959:Antihypertensive Agents; D002216:Captopril / Q000494:pharmacology; D004151:Dipeptides / Q000494:pharmacology; D004353:Drug Evaluation, Preclinical; D004656:Enalapril; D005260:Female; D006973:Hypertension / Q000503:physiopathology*; D006977:Hypertension, Renal / Q000503:physiopathology; D008297:Male; D051381:Rats; D011919:Rats, Inbred Strains; D053778:Thiazolidines
D000806:Angiotensin-Converting Enzyme Inhibitors; D000959:Antihypertensive Agents; D004151:Dipeptides; D053778:Thiazolidines; D004656:Enalapril; D002216:Captopril; D015097:3-Mercaptopropionic Acid; C033437:rentiapril